(WSVN) - The Center for Disease Prevention and Control has scheduled a major meeting to discuss two COVID-19 vaccines.
Advisors will get updates on reports of rare blood clots following the Johnson & Johnson vaccine, next Wednesday.
They will also have a discussion on the use of Pfizer’s vaccine in 12 to 15-year-old children.
The Food and Drug Administration is currently considering extending its emergency use authorization for that age group.
A federal official said the authorization could be expected by next week.
Copyright 2025 Sunbeam Television Corp. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.